Cargando…
Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de rhumatologie.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305295/ https://www.ncbi.nlm.nih.gov/pubmed/34314887 http://dx.doi.org/10.1016/j.jbspin.2021.105253 |
| _version_ | 1783727540316143616 |
|---|---|
| author | Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka |
| author_facet | Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka |
| author_sort | Richette, Pascal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8305295 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83052952021-07-26 Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka Joint Bone Spine Letter to the Editor Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. 2022-01 2021-07-24 /pmc/articles/PMC8305295/ /pubmed/34314887 http://dx.doi.org/10.1016/j.jbspin.2021.105253 Text en © 2021 Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases |
| title | Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases |
| title_full | Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases |
| title_fullStr | Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases |
| title_full_unstemmed | Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases |
| title_short | Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases |
| title_sort | impact of covid-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305295/ https://www.ncbi.nlm.nih.gov/pubmed/34314887 http://dx.doi.org/10.1016/j.jbspin.2021.105253 |
| work_keys_str_mv | AT richettepascal impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases AT allezmatthieu impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases AT descampsvincent impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases AT perraylucas impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases AT piletsimon impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases AT latourteaugustin impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases AT maravicmilka impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases |